» Authors » Thomas J Pugh

Thomas J Pugh

Explore the profile of Thomas J Pugh including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 65
Citations 1732
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sosa A, Rooney M, Thames H, Sanders J, Swanson D, Choi S, et al.
Clin Transl Radiat Oncol . 2024 Aug; 48:100822. PMID: 39188999
Background: Proton therapy (PT) has unique biologic properties with excellent clinical outcomes for the management of localized prostate cancer. Here, we aim to characterize the toxicity of PT for patients...
2.
Sosa A, Thames H, Sanders J, Choi S, Nguyen Q, Mok H, et al.
Radiother Oncol . 2023 Aug; 188:109854. PMID: 37597805
Background And Purpose: Proton therapy (PT) has emerged as a standard-of-care treatment option for localized prostate cancer at our comprehensive cancer center. However, there are few large-scale analyses examining the...
3.
4.
Pugh T
Tex Med J (Austin) . 2023 Mar; 9(12):640-641. PMID: 36954822
No abstract available.
5.
Pugh T
Tex Med J (Austin) . 2023 Mar; 9(4):170-172. PMID: 36954653
No abstract available.
6.
Pugh T
Daniels Tex Med J . 2023 Mar; 8(1):1-2. PMID: 36953651
No abstract available.
7.
Pugh T, Choi S, Nogueras-Gonzalaez G, Nguyen Q, Mahmood U, Frank S, et al.
Int J Part Ther . 2019 Nov; 3(1):27-36. PMID: 31772973
Purpose: To report prostate cancer outcomes, toxicity, and quality of life (QOL) in men treated with proton beam therapy (PBT). Patients And Methods: Patients were enrolled in a prospective trial....
8.
Gupta A, Pugh T, Lam E, Sheridan A, Nath S
Oncology (Williston Park) . 2019 May; 33(5):187-91. PMID: 31095719
No abstract available.
9.
Mason B, Eastham J, Davis B, Mynderse L, Pugh T, Lee R, et al.
J Natl Compr Canc Netw . 2019 May; 17(5):506-513. PMID: 31085758
Prostate cancer (PCa) represents a significant source of morbidity and mortality for men in the United States, with approximately 1 in 9 being diagnosed with PCa in their lifetime. The...
10.
Mohler J, Antonarakis E, Armstrong A, DAmico A, Davis B, Dorff T, et al.
J Natl Compr Canc Netw . 2019 May; 17(5):479-505. PMID: 31085757
The NCCN Guidelines for Prostate Cancer include recommendations regarding diagnosis, risk stratification and workup, treatment options for localized disease, and management of recurrent and advanced disease for clinicians who treat...